Intrum's stock sprang higher on the trading session as investors reacted to a set of company-specific developments that together improved the firm's near-term financial outlook. The shares rose 12.1 percent, trading at SEK 19.4, after UBS upgraded the credit management group from Neutral to Buy and established a SEK 28 price target.
UBS focused its upgrade on the implications of a guaranteed SEK 7.5 billion capital raise that Intrum announced alongside its Q1 2026 results on May 7. The bank told clients that the fully underwritten rights issue substantially reduces the company's refinancing tail risk and, in UBS's view, accelerates the timeline for deleveraging by roughly two years.
Management has framed the SEK 7.5 billion raise as a means to fast-track deleveraging and strengthen the balance sheet to support Intrum 2030. Company guidance indicates that approximately SEK 5 billion of the proceeds will be directed to debt reduction, while the remainder will be available to fund investment-led growth and targeted efficiency and technology projects. Management now expects to reach a leverage target of about 3.0x by 2028.
Adding an operational element to the financial restructuring, Intrum announced the close of its first co-investment transaction in Eastern Europe. The deal involves the acquisition of a Hungarian non-performing loan portfolio in partnership with a new European co-investor. The portfolio totals around SEK 1.25 billion and spans roughly 25,000 accounts.
Consistent with Intrum's capital-light approach, the company will hold a minority stake in the transaction and will manage the assets under a servicing agreement that runs for at least five years. Intrum described the arrangement as a way to generate recurring revenue streams while limiting capital deployment.
"Our first co-investment deal in Hungary, alongside a leading European investor, demonstrates how the combination of co-investment partnerships and long-term servicing agreements can create recurring revenue streams." - CEO Johan Åkerblom
Investor sentiment was likely bolstered further by the firm's senior leadership publicly backing the rights issue. The Chairman of the Board, the President & CEO, the CFO and other members of the Executive Management Team have stated their intent to subscribe for pro-rata shares in the Rights Issue, a show of insider conviction that market participants typically view favorably.
Markets beyond the company remained broadly neutral. U.S. benchmarks were mixed on the day - the S&P 500 edged down marginally, the Dow Jones posted a modest gain, and the NASDAQ slipped slightly - producing a largely neutral macro backdrop that left Intrum's own newsflow in focus.
Taken together, the UBS upgrade, the guaranteed capital raise designed to reduce refinancing risk and accelerate deleveraging, and the tangible execution of a capital-light co-investment in Hungary combined to lift investor confidence in Intrum's near-term path. The stock reached its highest levels in recent weeks on the news, though it remains well below its 52-week high of SEK 74.2.
What this means
- UBS's re-rating highlights how balance-sheet actions can prompt analyst reassessments when refinancing risk is addressed.
- The SEK 7.5 billion fully guaranteed raise shifts capital allocation toward debt paydown first, with remaining proceeds for growth and efficiency initiatives.
- The Hungarian co-investment evidences management's effort to expand recurring revenue under a capital-light model while maintaining a servicing role for at least five years.